Exploring which symptom should be targeted first in the comorbidity of anxiety and depression among adolescents with nomophobia: insight from a simulation network analysis

探讨在青少年手机依赖症合并焦虑和抑郁的共病中,应首先针对哪种症状进行干预:来自模拟网络分析的启示

阅读:1

Abstract

OBJECTIVES: To identify central and bridge symptoms linking anxiety and depression and to determine intervention-priority symptoms using simulation in Chinese college students with nomophobia. METHODS: A cross-sectional online survey recruited 1, 638 college students in China who met at least mild criteria for nomophobia. Depressive and anxiety symptoms were assessed with the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7). Ising networks were estimated for depression, anxiety, and their comorbidity. Expected influence and bridge expected influence were computed, and accuracy and stability were examined via nonparametric and case-dropping bootstraps. Network Intervention simulated analysis, symptom-specific alleviating and aggravating interventions to rank targets. RESULTS: Motor agitation/retardation (PHQ-8) and restlessness (GAD-5) were the most central symptoms in the depression and anxiety networks and remained central in the comorbidity network. Irritability (GAD-6) and feeling afraid (GAD-7) showed the highest bridge centrality, linking anxiety with depressive symptoms. NIRA indicated that reducing fatigue/low energy (PHQ-4) and excessive worry (GAD-3) would yield the largest decreases in overall network activation, whereas activating suicidal ideation (PHQ-9) and restlessness (GAD-5) would most strongly aggravate the network. Bootstrap results supported acceptable accuracy and stability (e.g., EI CS-C ≈.67 for depression;.60 for anxiety; bridge EI CS-C ≈.44 in the comorbidity network). CONCLUSIONS: Symptom-level analysis highlights actionable leverage points in nomophobia-related comorbidity. Longitudinal and experimental studies are warranted to confirm causal pathways and validate network-informed treatment sequencing.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。